Biogen Aktie - IDP

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

168,90

Gebot

168,95

Fragen

169,50

Volumen

412

168,30 Tagesbereich 172,85

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

24,602B

Handelsende

170,80

Handelsbeginn

171,55

Letzte Trade

168.9

Letzter Handelszeitpunkt

15:43:21

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

145.661.642

Dividendenrendite

Kurs-Gewinn-Verhältnis

23,68

Gewinn pro Aktie (EPS)

7,97

Erlöse

9,84B

Nettogewinn

1,16B

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.biogen.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker IDP. The last closing price for Biogen was 170,80 €. Over the last year, Biogen shares have traded in a share price range of 0,00 € to 0,00 €.

Biogen currently has 145.661.642 shares in issue. The market capitalisation of Biogen is 24,88 € billion. Biogen has a price to earnings ratio (PE ratio) of 23.68.

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024 Phase 3 PHOENYCS GO study...

Biogen Board Appoints Two New Independent Directors

Biogen Board Appoints Two New Independent Directors Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and...

Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA

Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA Positive study demonstrates the potential for...

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAIC

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The...

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease The collaboration aims to identify and develop accessible...

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease TOKYO and...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
EJ7Energy Resources of Australia	0,0055 € (37,50%)	215k
AAQ1AAP Implantate AG	2,10 € (36,36%)	6,4k
UMDKUMT United Mobility Technology	0,245 € (27,60%)	17,08k
5ZOLiMetal Corp	0,0478 € (23,83%)	5k
4HV0Maple Leaf Green World Inc	0,0385 € (20,31%)	20k
42EEmmerson Resources Ltd	0,017 € (-41,38%)	15k
47GAGo Metals Corp	0,0202 € (-33,11%)	1.000
4NM1China Evergrande New Energy Vehicle Group Limited	0,05 € (-23,43%)	33,14k
QHIShimao Group Holdings Limited	0,258 € (-19,38%)	5k
A8PAgile Group Holdings Limited	0,185 € (-18,86%)	20k
D7GNel ASA	0,3871 € (-1,88%)	3,07M
3CPXiaomi Corporation	2,77 € (-0,29%)	1,11M
QC8AFC Energy Plc	0,119 € (-2,94%)	696,57k
6LYWuling Motors Holdings Limited	0,0794 € (-7,24%)	636,39k
DEZDeutz AG	3,99 € (-9,93%)	559,29k

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Biogen Inc (IDP)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Biogen Inc

IDP Neueste Nachrichten

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

Biogen Board Appoints Two New Independent Directors

Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAIC

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Biogen Completes Acquisition of Human Immunology Biosciences

“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China

TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Biogen Inc (IDP) Börsenkurse

Biogen Inc (IDP)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Biogen Inc

IDP Neueste Nachrichten

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE